|
[1]
|
Nicolaou, A. and Kendall, A.C. (2024) Bioactive Lipids in the Skin Barrier Mediate Its Functionality in Health and Disease. Pharmacology & Therapeutics, 260, Article ID: 108681. https://doi.org/10.1016/j.pharmthera.2024.108681
|
|
[2]
|
Deng, Z., Cangkrama, M., Butt, T., Jane, S.M. and Carpinelli, M.R. (2021) Grainyhead‐Like Transcription Factors: Guardians of the Skin Barrier. Veterinary Dermatology, 32, 553-e152. https://doi.org/10.1111/vde.12956
|
|
[3]
|
Pancarte, M., Leignadier, J., Courrech, S., Serre, G., Attia, J. and Jonca, N. (2024) Strengthening the Skin Barrier by Using a Late Cornified Envelope 6A‐Derived Biomimetic Peptide. Experimental Dermatology, 33, e15191. https://doi.org/10.1111/exd.15191
|
|
[4]
|
Mischke, D., Korge, B.P., Marenholz, I., Volz, A. and Ziegler, A. (1996) Genes Encoding Structural Proteins of Epidermal Cornification and S100 Calcium-Binding Proteins Form a Gene Complex (“Epidermal Differentiation Complex”) on Human Chromosome 1q21. Journal of Investigative Dermatology, 106, 989-992. https://doi.org/10.1111/1523-1747.ep12338501
|
|
[5]
|
Wertz, P.W. (2025) A Provocation on Formation of the Corneocyte Lipid Envelope. Skin Pharmacology and Physiology, 38, 159-164. https://doi.org/10.1159/000546731
|
|
[6]
|
Moya-Garrido, P., Cano-Gómez, L.P., Ibarra-Molero, B., Godoy-Ruiz, R. and Medina-Carmona, E. (2026) Human Transglutaminases: Updated Insights into Activation Mechanisms, Allosteric Regulation and Disease. International Journal of Molecular Sciences, 27, Article 2976. https://doi.org/10.3390/ijms27072976
|
|
[7]
|
Ding, Y., Labitzky, V., Legler, K., Qi, M., Schumacher, U., Schmalfeldt, B., et al. (2021) Molecular Characteristics and Tumorigenicity of Ascites‐Derived Tumor Cells: Mitochondrial Oxidative Phosphorylation as a Novel Therapy Target in Ovarian Cancer. Molecular Oncology, 15, 3578-3595. https://doi.org/10.1002/1878-0261.13028
|
|
[8]
|
Zhang, S., Yao, H., Li, H., Su, T., Jiang, S., Wang, H., et al. (2023) Transglutaminases Are Oncogenic Biomarkers in Human Cancers and Therapeutic Targeting of TGM2 Blocks Chemoresistance and Macrophage Infiltration in Pancreatic Cancer. Cellular Oncology, 46, 1473-1492. https://doi.org/10.1007/s13402-023-00824-7
|
|
[9]
|
Chaudhary, R.K., Patil, P., Shetty, V.V., L., A., Shetty Kalladka, S., Mateti, U.V., et al. (2024) Decoding the Role of SPRR1A and SPRR1B Gene in Cancer: A Comprehensive Review. Gene Reports, 36, Article ID: 101926. https://doi.org/10.1016/j.genrep.2024.101926
|
|
[10]
|
Ishitsuka, Y. and Roop, D.R. (2022) Loricrin at the Boundary between inside and outside. Biomolecules, 12, Article 673. https://doi.org/10.3390/biom12050673
|
|
[11]
|
Wang, S. and Zhang, W. (2022) Small Proline-Rich Protein 1A Promotes Lung Adenocarcinoma Progression and Indicates Unfavorable Clinical Outcomes. Biochemistry and Cell Biology, 100, 199-212. https://doi.org/10.1139/bcb-2021-0348
|
|
[12]
|
Yang, S., Kang, W., Choi, D., Roh, J. and Park, T. (2024) Dihydromyrcenol Modulates Involucrin Expression through the Akt Signaling Pathway. International Journal of Molecular Sciences, 25, Article 2246. https://doi.org/10.3390/ijms25042246
|
|
[13]
|
Liu, L., Ding, L., Zhang, L., Zhang, H., Zhang, Y. and Liu, D. (2022) Mechanism of Periplakin on Ovarian Cancer Cell Phenotype and Its Influence on Prognosis. Translational Cancer Research, 11, 1372-1385. https://doi.org/10.21037/tcr-22-1090
|
|
[14]
|
Huang, C., Chen, Y., Bhutani, M.S., Wang, C., Zhou, Y., Guo, J., et al. (2025) The Plakin Family: Potential Therapeutic Targets for Digestive System Tumors. Journal of Translational Internal Medicine, 13, 397-409. https://doi.org/10.1515/jtim-2025-0033
|
|
[15]
|
Natsuga, K., Cipolat, S. and Watt, F.M. (2016) Increased Bacterial Load and Expression of Antimicrobial Peptides in Skin of Barrier-Deficient Mice with Reduced Cancer Susceptibility. Journal of Investigative Dermatology, 136, 99-106. https://doi.org/10.1038/jid.2015.383
|
|
[16]
|
Cipolat, S., Hoste, E., Natsuga, K., Quist, S.R. and Watt, F.M. (2014) Epidermal Barrier Defects Link Atopic Dermatitis with Altered Skin Cancer Susceptibility. eLife, 3, e01888. https://doi.org/10.7554/elife.01888
|
|
[17]
|
Shen, Y., Sun, W. and Dai, C. (2026) Comprehensive Analysis to Reveal Nitrogen Metabolism-Associated Genes as a Prognostic Index in Head and Neck Squamous Cell Cancer. Current Medicinal Chemistry, 33, 3313-3336. https://doi.org/10.2174/0109298673427009251022060122
|
|
[18]
|
Chatterjee, R., Ghosh, B., Mandal, M., Nawn, D., Banerjee, S., Pal, M., et al. (2021) Pathophysiological Relationship between Hypoxia Associated Oxidative Stress, Epithelial-Mesenchymal Transition, Stemness Acquisition and Alteration of Shh/Gli-1 Axis during Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma. European Journal of Cell Biology, 100, Article ID: 151146. https://doi.org/10.1016/j.ejcb.2020.151146
|
|
[19]
|
Preetika, S., Indhuja, V. and Sowmya, C. (2023) Oral Submucous Fibrosis: A Review on Current Treatment Approaches. World Journal of Biology Pharmacy and Health Sciences, 13, 157-162. https://doi.org/10.30574/wjbphs.2023.13.2.0088
|
|
[20]
|
Dash, K., Mahapatra, N., Bhuyan, L., Panda, A., Behura, S. and Mishra, P. (2020) Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis. Journal of Pharmacy and Bioallied Sciences, 12, 264-267. https://doi.org/10.4103/jpbs.jpbs_79_20
|
|
[21]
|
Odani, T., Ito, D., Li, M., Kawamata, A., Isobe, T., Iwase, M., et al. (2006) Gene Expression Profiles of Oral Leukoplakia and Carcinoma: Genome-Wide Comparison Analysis Using Oligonucleotide Microarray Technology. International Journal of Oncology, 28, 619-624. https://doi.org/10.3892/ijo.28.3.619
|
|
[22]
|
Pandey, S., Søland, T.M., Bjerkli, I.H., Sand, L.P., Petersen, F.C., Costea, D.E., et al. (2021) Combined Loss of Expression of Involucrin and Cytokeratin 13 Is Associated with Poor Prognosis in Squamous Cell Carcinoma of Mobile Tongue. Head & Neck, 43, 3374-3385. https://doi.org/10.1002/hed.26826
|
|
[23]
|
Lee, M.K., Joo, H., Bae, M., Lee, Y., Noh, J., Lee, Y.C., et al. (2026) Keratinization-Related Gene Signature Predicting Survival and Response to Radiation in Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma via Regulation of Cornification and Integrin Signaling. Cellular & Molecular Biology Letters, 31, Article No. 26. https://doi.org/10.1186/s11658-025-00855-y
|
|
[24]
|
Chou, S., Azuma, Y., Varia, M.A. and Raleigh, J.A. (2004) Evidence That Involucrin, a Marker for Differentiation, Is Oxygen Regulated in Human Squamous Cell Carcinomas. British Journal of Cancer, 90, 728-735. https://doi.org/10.1038/sj.bjc.6601585
|
|
[25]
|
Sasahira, T., Kurihara-Shimomura, M., Shimomura, H., Bosserhoff, A.K. and Kirita, T. (2021) Identification of Oral Squamous Cell Carcinoma Markers MUC2 and SPRR1B Downstream of Tango. Journal of Cancer Research and Clinical Oncology, 147, 1659-1672. https://doi.org/10.1007/s00432-021-03568-9
|
|
[26]
|
Burian, A., Lujber, L., Gerlinger, I., Jarai, T., Orosz, E., Turiak, L., et al. (2020) Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples—A Pilot Study. Pathology & Oncology Research, 26, 2801-2807. https://doi.org/10.1007/s12253-020-00849-5
|
|
[27]
|
Ogawa, T., Ishitsuka, Y., Nakamura, Y., Watanabe, R., Okiyama, N., Fujisawa, Y., et al. (2022) Loricrin Protects against Chemical Carcinogenesis. Journal of Investigative Dermatology, 142, 2023-2026.e1. https://doi.org/10.1016/j.jid.2021.12.015
|
|
[28]
|
Santiago, J.L., Muñoz-Rodriguez, J.R., Cruz-Morcillo, M.A.D.L., Villar-Rodriguez, C., Gonzalez-Lopez, L., Aguado, C., et al. (2021) Characterization of Permeability Barrier Dysfunction in a Murine Model of Cutaneous Field Cancerization Following Chronic UV-B Irradiation: Implications for the Pathogenesis of Skin Cancer. Cancers, 13, Article 3935. https://doi.org/10.3390/cancers13163935
|
|
[29]
|
Liu, B., Park, E., Zhu, F., Bustos, T., Liu, J., Shen, J., et al. (2006) A Critical Role for IκB Kinase Α in the Development of Human and Mouse Squamous Cell Carcinomas. Proceedings of the National Academy of Sciences of the United States of America, 103, 17202-17207. https://doi.org/10.1073/pnas.0604481103
|
|
[30]
|
Ewen, T., Husain, A., Stefanos, N., Barrett, P., Jones, C., Ness, T., et al. (2023) Validation of Epidermal AMBRA1 and Loricrin (AMBLor) as a Prognostic Biomarker for Nonulcerated American Joint Committee on Cancer Stage I/II Cutaneous Melanoma. British Journal of Dermatology, 190, 549-558. https://doi.org/10.1093/bjd/ljad459
|
|
[31]
|
Cosgarea, I., McConnell, A.T., Ewen, T., Tang, D., Hill, D.S., Anagnostou, M., et al. (2021) Melanoma Secretion of Transforming Growth Factor‐β2 Leads to Loss of Epidermal AMBRA1 Threatening Epidermal Integrity and Facilitating Tumour Ulceration. British Journal of Dermatology, 186, 694-704. https://doi.org/10.1111/bjd.20889
|
|
[32]
|
Cai, W. and Chen, M. (2024) Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma through the RAS/ERK Signaling Pathway. Journal of Inflammation Research, 17, 1687-1706. https://doi.org/10.2147/jir.s447934
|
|
[33]
|
Li, B., Wang, X., Zhou, F., Saunders, N.A., Frazer, I.H. and Zhao, K. (2008) Up-Regulated Expression of Sp1 Protein Coincident with a Viral Protein in Human and Mouse Differentiating Keratinocytes May Act as a Cell Differentiation Marker. Differentiation, 76, 1068-1080. https://doi.org/10.1111/j.1432-0436.2008.00300.x
|
|
[34]
|
Nishimori, T., Tomonaga, T., Matsushita, K., Oh‐Ishi, M., Kodera, Y., Maeda, T., et al. (2006) Proteomic Analysis of Primary Esophageal Squamous Cell Carcinoma Reveals Downregulation of a Cell Adhesion Protein, Periplakin. Proteomics, 6, 1011-1018. https://doi.org/10.1002/pmic.200500262
|
|
[35]
|
Otsubo, T., Hagiwara, T., Tamura‐Nakano, M., Sezaki, T., Miyake, O., Hinohara, C., et al. (2015) Aberrant DNA Hypermethylation Reduces the Expression of the Desmosome‐Related Molecule Periplakin in Esophageal Squamous Cell Carcinoma. Cancer Medicine, 4, 415-425. https://doi.org/10.1002/cam4.369
|
|
[36]
|
Roy, R.R., Shimada, K., Murakami, S. and Hasegawa, H. (2021) Contribution of Transglutaminases and Their Substrate Proteins to the Formation of Cornified Cell Envelope in Oral Mucosal Epithelium. European Journal of Oral Sciences, 129, e12760. https://doi.org/10.1111/eos.12760
|
|
[37]
|
Song, T., Chen, J., Xing, P., Hao, H., Yang, X., Chen, B., et al. (2025) Multi-OMIC Profiling Identifies KRT1 as a Predictor of Immune Infiltration and Prognosis in Gastroesophageal Junction Cancer. Functional & Integrative Genomics, 25, Article No. 89. https://doi.org/10.1007/s10142-025-01595-0
|
|
[38]
|
Sun, S., Huang, F., Xu, X., Xu, K., Peng, T., Bai, W., et al. (2024) Development and Validation of a Prediction Model for Gastric Cancer: A Single-Center Prospective Study. Laboratory Medicine, 56, 31-36. https://doi.org/10.1093/labmed/lmae060
|
|
[39]
|
许晓明, 董学妍, 陈岳明, 余道军, 王贤军. 富含脯氨酸小蛋白2A对胃癌细胞增殖和迁移能力的影响[J]. 实用肿瘤杂志, 2020, 35(6): 511-517.
|
|
[40]
|
Yao, L., Yan, J., Cheng, F., Gan, L., Huang, Y., Zheng, L., et al. (2021) Small Proline-Rich Protein 2B Facilitates Gastric Adenocarcinoma Proliferation via MDM2-p53/p21 Signaling Pathway. OncoTargets and Therapy, 14, 1453-1463. https://doi.org/10.2147/ott.s281032
|
|
[41]
|
Li, X., Zhang, G., Wang, Y., Elgehama, A., Sun, Y., Li, L., et al. (2017) Loss of Periplakin Expression Is Associated with the Tumorigenesis of Colorectal Carcinoma. Biomedicine & Pharmacotherapy, 87, 366-374. https://doi.org/10.1016/j.biopha.2016.12.103
|
|
[42]
|
Zhang, Z., Shi, R., Xu, S., Li, Y., Zhang, H., Liu, M., et al. (2021) Identification of Small Proline‐Rich Protein 1B (SPRR1B) as a Prognostically Predictive Biomarker for Lung Adenocarcinoma by Integrative Bioinformatic Analysis. Thoracic Cancer, 12, 796-806. https://doi.org/10.1111/1759-7714.13836
|
|
[43]
|
Yu, L., Yang, Z., Liu, Y., Liu, F., Shang, W., Shao, W., et al. (2020) Identification of SPRR3 as a Novel Diagnostic/Prognostic Biomarker for Oral Squamous Cell Carcinoma via RNA Sequencing and Bioinformatic Analyses. PeerJ, 8, e9393. https://doi.org/10.7717/peerj.9393
|
|
[44]
|
Box, C., Pennington, C., Hare, S., Porter, S., Edwards, D., Eccles, S., et al. (2023) Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3. International Journal of Molecular Sciences, 24, Article 10757. https://doi.org/10.3390/ijms241310757
|
|
[45]
|
Geay, J., Margaron, Y., Gentien, D., Reyal, F., Puisieux, A., Blanchoin, L., et al. (2024) Plakins Are Involved in the Regulation of Centrosome Position in Polarized Epithelial Cells. Biology of the Cell, 116, e2400048. https://doi.org/10.1111/boc.202400048
|
|
[46]
|
Cheng, H., Wang, R., Lu, L., Gong, Y., Li, L. and Wang, Z. (2024) Bladder Cancer Patients with Elevated SPRR1B Expression Experiencing a Poor Prognosis. Archivos Españoles de Urología, 77, 554-569. https://doi.org/10.56434/j.arch.esp.urol.20247705.76
|
|
[47]
|
Matsumoto, K., Ikeda, M., Matsumoto, T., Nagashio, R., Nishimori, T., Tomonaga, T., et al. (2014) Serum Periplakin as a Potential Biomarker for Urothelial Carcinoma of the Urinary Bladder. Asian Pacific Journal of Cancer Prevention, 15, 9927-9931. https://doi.org/10.7314/apjcp.2014.15.22.9927
|
|
[48]
|
Wesley, T., Escalona, R.M., Kannourakis, G. and Ahmed, N. (2024) Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and in Silico Datasets. Cancers, 16, Article 4087. https://doi.org/10.3390/cancers16234087
|
|
[49]
|
Hua, T., Zhao, B.B., Fan, S.B., Zhao, C.F., Kong, Y.H., Tian, R.Q., et al. (2022) Prognostic Implications of PPL Expression in Ovarian Cancer. Discover Oncology, 13, Article No. 35. https://doi.org/10.1007/s12672-022-00496-z
|
|
[50]
|
Al-Jassar, C., Bernadό, P., Chidgey, M. and Overduin, M. (2013) Hinged Plakin Domains Provide Specialized Degrees of Articulation in Envoplakin, Periplakin and Desmoplakin. PLOS ONE, 8, e69767. https://doi.org/10.1371/journal.pone.0069767
|
|
[51]
|
Spain, F., Gimenez, D., Acevedo-Jake, A.M., Mylemans, B., Brooks, N.J., Korona, B., et al. (2026) De novo Grafted Coiled-Coil Peptides as p53/hDM2 Inhibitors. RSC Chemical Biology, 7, 1589-1596. https://doi.org/10.1039/d6cb00063k
|
|
[52]
|
Yamakawa, K., Koyanagi-Aoi, M., Uehara, K., Masuda, A., Yanagimoto, H., Toyama, H., et al. (2022) Increased Expression of SPRR1A Is Associated with a Poor Prognosis in Pancreatic Ductal Adenocarcinoma. PLOS ONE, 17, e0266620. https://doi.org/10.1371/journal.pone.0266620
|
|
[53]
|
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., et al. (2025) SPRR1A Is a Potential Therapeutic Target for Osteosarcoma: In Vitro and in Vivo Evaluations Using Generated Artificial Osteosarcoma Cancer Stem Cell-Like Cells. Oncology Reports, 53, Article No. 24. https://doi.org/10.3892/or.2024.8857
|
|
[54]
|
Zabini, A., Zimmer, Y. and Medová, M. (2023) Beyond Keratinocyte Differentiation: Emerging New Biology of Small Proline-Rich Proteins. Trends in Cell Biology, 33, 5-8. https://doi.org/10.1016/j.tcb.2022.08.002
|
|
[55]
|
Wu, M., Guo, Q., Liu, X. and Wu, L. (2022) SPRR3, a Novel miR-338-3p Target, Regulates the Malignant Progression of Clear Cell Renal Cell Carcinoma in Vitro via the PI3K/Akt Signaling Pathway. Experimental and Therapeutic Medicine, 23, Article No. 317. https://doi.org/10.3892/etm.2022.11246
|
|
[56]
|
Shi, Y.X. (2026) Multi-Omics Analysis Identified SPRR2D as a Potential Biomarker for Tumor Prognosis and Immune Microenvironment Infiltration: A Pan-Cancer Perspective. Future Science OA, 12, Article ID: 2653101. https://doi.org/10.1080/20565623.2026.2653101
|